Efficacy and Tolerability of HAT1 in Patients With Moderate to Severe Atopic Dermatitis
Clinical trial NCT03059693 · COMPLETED
Trial details
- NCT number
- NCT03059693
- Sponsor
- Haus Bioceuticals
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-29
- Primary completion
- 2016-06-13
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.